Search Results - "Mastroianni, Claudio M"

Refine Results
  1. 1
  2. 2
  3. 3

    Is previous influenza-like illness a potential Trojan horse for COVID-19? by Ceccarelli, Giancarlo, d'Ettorre, Gabriele, Innocenti, Giuseppe Pietro, Mastroianni, Claudio M, Ciccozzi, Massimo, d'Ettorre, Gabriella

    Published in Critical care (London, England) (14-08-2020)
    “…In confirmation of this, interestingly, a number of ILI-related viral pathogens (i.e. respiratory syncytial virus and influenza virus) have been reported to…”
    Get full text
    Journal Article
  4. 4

    Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii by Oliva, Alessandra, Ceccarelli, Giancarlo, De Angelis, Massimiliano, Sacco, Federica, Miele, Maria Claudia, Mastroianni, Claudio M, Venditti, Mario

    “…•A real-life experience with cefiderocol for XDR-Ab is presented.•Clinical improvement and microbiological eradication occurred in all three patients.•High…”
    Get full text
    Journal Article
  5. 5

    Face Mask Use in the Community for Reducing the Spread of COVID-19: A Systematic Review by Coclite, Daniela, Napoletano, Antonello, Gianola, Silvia, Del Monaco, Andrea, D'Angelo, Daniela, Fauci, Alice, Iacorossi, Laura, Latina, Roberto, Torre, Giuseppe La, Mastroianni, Claudio M, Renzi, Cristina, Castellini, Greta, Iannone, Primiano

    Published in Frontiers in medicine (12-01-2021)
    “…Evidence is needed on the effectiveness of wearing face masks in the community to prevent SARS-CoV-2 transmission. Systematic review and meta-analysis to…”
    Get full text
    Journal Article
  6. 6

    Molecular mechanisms of liver fibrosis in HIV/HCV coinfection by Mastroianni, Claudio M, Lichtner, Miriam, Mascia, Claudia, Zuccalà, Paola, Vullo, Vincenzo

    “…Chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in people coinfected with human immunodeficiency virus (HIV)…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii by Oliva, Alessandra, Garzoli, Stefania, De Angelis, Massimiliano, Marzuillo, Carolina, Vullo, Vincenzo, Mastroianni, Claudio M, Ragno, Rino

    Published in Molecules (Basel, Switzerland) (03-03-2019)
    “…Carbapenem-resistant (CR-Ab) infections are associated with high morbidity and mortality. The aim of the study was to evaluate the in-vitro activity of…”
    Get full text
    Journal Article
  10. 10

    Oxygen Sparing Effect of Bacteriotherapy in COVID-19 by Ceccarelli, Giancarlo, Marazzato, Massimiliano, Celani, Luigi, Lombardi, Francesca, Piccirilli, Alessandra, Mancone, Massimo, Trinchieri, Vito, Pugliese, Francesco, Mastroianni, Claudio M, d’Ettorre, Gabriella

    Published in Nutrients (01-08-2021)
    “…Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Sonication of Explanted Cardiac Implants Improves Microbial Detection in Cardiac Device Infections by Oliva, Alessandra, Nguyen, Bich Lien, Mascellino, Maria T, D'Abramo, Alessandra, Iannetta, Marco, Ciccaglioni, Antonio, Vullo, Vincenzo, Mastroianni, Claudio M

    Published in Journal of Clinical Microbiology (01-02-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Current trends in management of hepatitis B virus reactivation in the biologic therapy era by Mastroianni, Claudio M, Lichtner, Miriam, Citton, Rita, Del Borgo, Cosmo, Rago, Angela, Martini, Helene, Cimino, Giuseppe, Vullo, Vincenzo

    Published in World journal of gastroenterology : WJG (14-09-2011)
    “…Hepatitis B virus (HBV) reactivation represents an emerging cause of liver disease in patients undergoing treatment with biologic agents. In particular, the…”
    Get full text
    Journal Article